Joint response to an EMA public consultation

The European Medicines Agency (EMA) must stay true to the Clinical Trials Regulation: non-disclosure has to remain the exception, not become the norm! 

Press release and joint response attached as PDF: 

Attachment: 2015_02_jointpressrelease_addendumema.pdf